Diagnostic and prognostic significance of mast cell markers in HIV/AIDS: Current insights and future directions

Emmanuel Ifeanyi Obeagu
DOI: https://doi.org/10.1097/md.0000000000038117
IF: 1.6
2024-05-19
Medicine
Abstract:Human immunodeficiency virus (HIV) infection remains a profound global health concern, necessitating precise diagnostic tools and prognostic indicators to optimize disease management and therapeutic interventions. [ 1 ] Amidst the intricate landscape of immune responses, mast cells have garnered attention for their potential diagnostic and prognostic significance in HIV/AIDS. [ 2 ] This paper aims to provide a comprehensive overview of the current understanding, challenges, and future prospects surrounding the utility of mast cell markers in diagnosing HIV infection, predicting disease progression, and guiding therapeutic approaches. Mast cells, traditionally acknowledged for their involvement in allergic reactions and host defense against parasites, have exhibited multifaceted roles in immune responses beyond their conventional functions. [ 3 ] Recent research has unveiled their capacity to act as sentinels in various tissues, expressing unique markers such as tryptase, chymase, carboxypeptidase A3, and c-kit/CD117 receptors. [ 4 , 5 ] These markers, identified in different tissue microenvironments and body fluids, present intriguing prospects as potential diagnostic tools for HIV infection. [ 6 ] Moreover, beyond their diagnostic implications, the prognostic value of mast cell markers in HIV/AIDS represents a burgeoning area of investigation. The intricate interplay between mast cell activation, tissue distribution, and their association with disease severity offers potential insights into predicting disease progression, immune dysregulation, and clinical outcomes in individuals living with HIV/AIDS. [ 7 ]
medicine, general & internal
What problem does this paper attempt to address?